Senior insider sale
Chief Financial Officer at AARDVARK THERAPEUTICS, INC. — senior position signals high conviction
$210.8K
42.84K shares
What this filing means
SUN NELSON plans to sell 42.84K shares of AARDVARK THERAPEUTICS, INC. valued at approximately $210.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/10/2026ACC: 0001950047-26-009316
Officer· Chief Financial Officer
Since Feb 2026
42.84K
Shares to sell
$210.8K
Approx. market value
42.84K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Open Market Purchase
N/A
9/9/2025
2KPreviously Exercised Options
Cash
9/26/2024
33.84KSeries C Preferred
N/A
5/1/2024
7KTotal acquired42.84K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/9/2025 | Open Market Purchase N/A | 2K | — |
9/26/2024 | Previously Exercised Options Cash | 33.84K | — |
5/1/2024 | Series C Preferred N/A | 7K | — |
| Total | 42.84K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
42.84K
Market value
$210.8K
9/10/2026
Total
Units
42.84K
Value
$210.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/10/2026 | 42.84K | $210.8K | NASDAQ | Planned |
| Total | 42.84K | $210.8K | ||